Ceros Financial Services arranges $7.5 million financing for Wesper

Copyright 2022 PR Newswire. All rights reserved

Wesper Home Sleep Lab includes a wearable device that monitors sleep conditions For clinical-grade assessment, analysis and treatment

MIAMI, November 8, 2022 /PRNewswire/ — Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed a $7.5 million Series A cycle for Wesper, which developed the first FDA-cleared, clinical-grade platform to deliver the complete cycle of sleep therapy to home users.

Wesper’s sensors and algorithms provide in-home medical diagnosis and continuous measurements, before, during and after treatment. With Wesper, users have access to personalized and professional advice from sleep specialists without having to leave their home.

“Millions of people suffer from poor sleep, but many never receive feedback or assistance due to the lack of easy sleep testing. Wesper essentially provides a home sleep lab with professional advice,” said Marc GoldwasserCEO of Ceros Financial Services.

Ceros is focused on raising funds for early-stage medical technology and medical device companies that are developing disruptive technologies for diagnostic and non-invasive procedures. Since 2020, Ceros has achieved approximately $165 million in medical technology transactions. The company aims to raise approximately $100 million over the next twelve months, Goldwasser said.

Recent offerings from Ceros include $15 million for GT Metabolic Solutions, which has developed an incisionless bariatric and digestive surgery technology, and a $18 million funding round with Peregrine Ventures for Cordio Medical, which has developed technology to monitor changes in chronic heart failure conditions through the analysis of recorded voice samples in a simple smartphone app.

Ceros has also placed an additional $10 million for DemaSensor, which designs non-invasive tools that use machine learning and spectroscopy to assess skin lesions for cancer, and $15 million for Pristine Surgical, which has developed a single-use platform for endoscopic procedures.

About Ceros Financial Services, Inc.

Ceros Financial Services, Inc. Member FINRA/SIPC (www.cerosfs.com) offers a comprehensive asset and mutual fund management suite for financial advisors. Ceros services include RIA custody, hybrid advisors, corporate RIA, mutual fund advisory and distribution, and an outsourced dealing desk. In addition, Ceros Capital Markets, a division of Ceros Financial, is a digital and traditional platform for the distribution of primary offers in medical devices and secondary offers in unicorns via Special Purpose Vehicles (SPV).

Investing in stock markets involves risk, including loss of principal. Private placements are not suitable for all investors. Most, if not all, investments in private placements are illiquid and many of these investments are speculative in nature. Investing in a private placement may entail a significant risk of loss of capital. Risk factors for private offerings are listed in the private placement memorandum; and should be read carefully before investing.

View original content: https://www.prnewswire.com/news-releases/ceros-financial-services-arranges-7-5-million-financing-for-wesper-301671824.html

SOURCECeros Financial Services

Stephen V. Lee